MPTX1: A Pseudogene with Potential Drug Targets (G649458)

Target Name: MPTX1

NCBI ID: G649458

MPTX1

Other Name(s): mucosal pentraxin 1 (pseudogene) | MPTX | Mucosal pentraxin 1 (pseudogene)

MPTX1: A Pseudogene with Potential Drug Targets

MPTX1, also known as mucosal pentraxin 1 (pseudogene), is a gene that has been identified as a potential drug target or biomarker for various diseases, including inflammatory bowel disease, chronic obstructive pulmonary disease (COPD), and asthma. The study of MPTX1 and its potential therapeutic applications has gained significant attention in the scientific community due to its unique genetic makeup and its association with various diseases.

MPTX1 is a pseudogene, which means that it is a genetic copy of a gene that does not have any function. However, the genetic sequence of MPTX1 is highly conserved across various species, which suggests that it may have evolved from a common ancestor gene. The gene is located on chromosome 12q21 and has a length of 254 base pairs.

Studies have shown that MPTX1 is expressed in various tissues and organs, including the skin, gut, and respiratory tract. It is also highly expressed in tissues affected by diseases, such as inflammatory bowel disease and COPD. This suggests that MPTX1 may be a promising biomarker or drug target for these diseases.

One of the key features of MPTX1 is its ability to interact with various signaling pathways. For example, it has been shown to be involved in the TGF-β pathway, which is a well-known signaling pathway involved in cell growth, differentiation, and inflammation. Additionally, MPTX1 has been shown to interact with the NF-kappa-B pathway, which is involved in inflammation and immune responses.

MPTX1 has also been shown to play a role in the regulation of inflammation and immune cell function. For example, studies have shown that MPTX1 can inhibit the production of pro-inflammatory cytokines, such as TNF-伪 and IL-12, which are involved in inflammation and immune responses. This suggests that MPTX1 may be a useful drug target for diseases that are characterized by chronic inflammation, such as inflammatory bowel disease and COPD.

Another potential application of MPTX1 as a drug target is its role in the regulation of cell adhesion. MPTX1 has been shown to play a role in the formation of tight junctions, which are a type of cell adhesion structure that helps to maintain the integrity of tissues and organs. This suggests that MPTX1 may be a useful target for diseases that are characterized by disrupted cell adhesion, such as cancer.

In conclusion, MPTX1 is a promising gene that has been shown to play a role in various diseases, including inflammatory bowel disease, COPD, and asthma. Its unique genetic makeup and its association with various diseases make it an attractive target for further research and development. Further studies are needed to fully understand the role of MPTX1 in disease and to identify potential therapeutic applications.

Protein Name: Mucosal Pentraxin 1 (pseudogene)

The "MPTX1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MPTX1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets